W
Wenjie Zeng
Researcher at Chongqing Jiaotong University
Publications - 10
Citations - 215
Wenjie Zeng is an academic researcher from Chongqing Jiaotong University. The author has contributed to research in topics: Formulary & Pattern recognition (psychology). The author has an hindex of 6, co-authored 8 publications receiving 197 citations.
Papers
More filters
Journal ArticleDOI
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems
Brian Godman,Rickard E. Malmström,Eduardo Diogene,Andy Gray,Sisira Jayathissa,Angela Timoney,Francisco de Assis Acurcio,Ali Alkan,Anna Brzezinska,Anna Bucsics,Stephen Campbell,Jadwiga Czeczot,Winnie de Bruyn,Irene Eriksson,Faridah Yusof,Alexander E. Finlayson,Jurij Fürst,Kristina Garuoliene,Augusto Afonso Guerra Junior,Jolanta Gulbinovič,Saira Jan,Roberta Joppi,Marija Kalaba,Einar Magnisson,Laura McCullagh,Kaisa Miikkulainen,Gabriela Ofierska-Sujkowska,Hanne Bak Pedersen,Gisbert Selke,Catherine Sermet,Susan Spillane,Azuwana Supian,Ilse Truter,Vera Vlahović-Palčevski,Low Ee Vien,Elif Hilal Vural,Janet Wale,Magdalene Wladysiuk,Wenjie Zeng,Lars L. Gustafsson +39 more
TL;DR: The objective is to review case histories among health authorities to improve the utilization and expenditure on new medicines, as well as develop exemplar models for valuing medicines for orphan diseases alongside potentially capping pharmaceutical expenditure.
Journal ArticleDOI
Prescribing efficiency of proton pump inhibitors in China: influence and future directions.
Wenjie Zeng,Alexander E. Finlayson,Sushma Shankar,Winnie de Bruyn,Brian Godman,Brian Godman,Brian Godman +6 more
TL;DR: Assessing changes in proton pump inhibitor (PPI) utilisation and expenditure in China as more generics become available including injectables finds considerable opportunities to enhance prescribing efficiency through greater use of oral generic omeprazole.
Journal ArticleDOI
A price and use comparison of generic versus originator cardiovascular medicines: a hospital study in Chongqing, China
TL;DR: The market share of the generics was lowering and the weighted mean price kept increasing in face of the strict price control in China.
Journal ArticleDOI
Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction
Wenjie Zeng,Junjie Zhen,Mengying Feng,Stephen Campbell,Stephen Campbell,Alexander E. Finlayson,Brian Godman +6 more
TL;DR: Price still have an appreciable impact on utilization in China and potential measures similar to those implemented among western European countries could improve prescribing rationality and conserve resources.
Journal ArticleDOI
Review of ongoing initiatives to improve prescribing efficiency in China; angiotensin receptor blockers as a case history.
TL;DR: Considerable opportunities to improve prescribing efficiency in China are found as more generics become available and prices typically reduced over time, mirroring price reductions in some European countries.